Viatris reported 22.25 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
Adcock Ingram Holdings 12.74 1.79 Jun/2024
Celltrion 91.32 14.94 Mar/2025
Cspc Pharmaceutical 12.94 0.45 Mar/2025
Divis Laboratories Ltd 87.49 13.33 Jun/2025
Kangmei Pharma 126.35 9.9 Sep/2024
Knight Therapeutics 43.03 21.94 Dec/2021
Laboratorios Farma 20.04 0.23 Jun/2025
Malin Corporation 11.81 0.72 Jun/2023
Medical Developments International 1.17K 765.75 Jun/2020
Neuren Pharmaceuticals 13.64 3.76 Jun/2024
Pharma Mar 70.33 15.83 Jun/2025
Qiagen NV 24.01 79.75 Jun/2025
Sartorius 156.52 20.01 Jun/2025
Sino Biopharmaceutical 27.73 0.61 Jun/2024
Viatris 22.25 216.55 Jun/2025
Zz Pientze Pharmaceu 44.7 5.04 Jun/2025